|The CCNG1 ccng1 (Catalog #MBS9218225) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The CCNG1 ccng1 product has the following accession number(s) (GI #2506334) (NCBI Accession #P51959.2) (Uniprot Accession #P51959). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
May play a role in growth regulation. Is associated with G2/M phase arrest in response to DNA damage. May be an intermediate by which p53 mediates its role as an inhibitor of cellular proliferation (By similarity).
Cellular Location: Nucleus. Note: DNA replication foci after DNA damage. Tissue Location: High levels in skeletal muscle, ovary, kidney and colon. Adenocarcinoma, Brain Diseases, Breast Neoplasms, Carcinoma, Carcinoma, Hepatocellular, Disease Models, Animal, Liver Diseases, Liver Neoplasms, Neoplasms, Experimental, Nervous System Diseases are some of the diseases may be linked to CCNG1 Antibody (C-term) Blocking peptide. Blood, Brain, Heart, Kidney, Liver, Lung, Muscle, Nerve, Uterus, Vascular tissues are correlated with this protein. The following patways have been known to be associated with this gene. CCNG1 also interacts with the following gene(s): CCNB1, CCNF, CDK2, CDK5, MDM2, MYC, TP53.